During the past decade, Palmetto Retinal Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Palmetto Retinal Center" are "Age-Related Macular Degeneration" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetic Macular Edema" (1 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Palmetto Retinal Center" in a lesser frequency.

Most popular intervention types in "Palmetto Retinal Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "E10030 plus Lucentis" (1 trials), "Lucentis" (1 trials), "THR-687 dose level 1" (1 trials), "THR-687 dose level 2" (1 trials) and "THR-687 dose level 3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Palmetto Retinal Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Palmetto Retinal Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Palmetto Retinal Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Palmetto Retinal Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".